CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | 0.0% | 1,984 | +103.1% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 977 | +51.5% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 645 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 645 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | -33.3% | 645 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | +50.0% | 645 | +6.1% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 608 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -90.9% | 608 | -70.9% | 0.00% | -100.0% |
| Q4 2019 | $11,000 | +57.1% | 2,088 | -6.0% | 0.00% | – |
| Q3 2019 | $7,000 | +75.0% | 2,222 | +120.9% | 0.00% | – |
| Q2 2019 | $4,000 | +300.0% | 1,006 | +241.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 295 | -0.3% | 0.00% | – |
| Q4 2018 | $1,000 | -80.0% | 296 | -48.6% | 0.00% | – |
| Q3 2018 | $5,000 | +400.0% | 576 | +433.3% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 108 | +10.2% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 98 | +27.3% | 0.00% | – |
| Q3 2017 | $1,000 | -83.3% | 77 | -83.5% | 0.00% | -100.0% |
| Q2 2017 | $6,000 | +20.0% | 466 | +110.9% | 0.00% | – |
| Q1 2017 | $5,000 | – | 221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $11,661,000 | 2.42% |
| Telemetry Investments, L.L.C. | 189,081 | $673,000 | 1.14% |
| CHI Advisors LLC | 490,877 | $1,748,000 | 0.49% |
| BVF INC/IL | 1,943,712 | $6,920,000 | 0.27% |
| Orbimed Advisors | 6,767,584 | $24,093,000 | 0.21% |
| Novo Holdings A/S | 847,906 | $3,019,000 | 0.13% |
| Golden Green, Inc. | 19,539 | $70,000 | 0.06% |
| ALGERT GLOBAL LLC | 15,467 | $55,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $476,000 | 0.01% |
| Hikari Power Ltd | 19,959 | $71,000 | 0.01% |